[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352639-105":59,"doc-detail-352639-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","rest-and-rassf1a-tumor-suppressor-genes-in-peripheral-blood-potential-molecular-markers-in-breast-cancer","REST and RASSF1A Tumor Suppressor Genes in Peripheral Blood: Potential Molecular Markers in Breast Cancer","","Tumor suppressor genes REST and RASSF1A regulate cell proliferation and influence cancer behavior. RASSF1A is often inactivated across cancers and linked to unfavorable outcomes, while REST loss supports gene programs related to invasion and estrogen sensitivity. This study assessed REST and RASSF1A expression in peripheral blood from breast cancer patients at diagnosis and 3/6 months after chemotherapy, compared with healthy controls, using qPCR and correlation with clinical and laboratory variables.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/rest-and-rassf1a-tumor-suppressor-genes-in-peripheral-blood-potential-molecular-markers-in-breast-cancer/352639/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/rest-and-rassf1a-tumor-suppressor-genes-in-peripheral-blood-potential-molecular-markers-in-breast-cancer/352639.png","ImageObject",300,407,{"name":92,"@type":93},"\tCallum ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-19","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main aim of measuring REST and RASSF1A in this study?","Question",{"text":112,"@type":113},"The study aims to evaluate REST and RASSF1A expression in the peripheral blood of breast cancer patients at different treatment stages and relate the findings to clinical and laboratory variables.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were patient and control samples collected and analyzed?",{"text":117,"@type":113},"Peripheral blood samples were collected from breast cancer patients at diagnosis and at 3 and 6 months after starting chemotherapy, and from healthy women. Gene expression was quantified using qPCR and analyzed against clinical variables.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the study find regarding REST and clinical variables?",{"text":121,"@type":113},"REST expression was significantly lower in patients, with a negative correlation with BIRADS classification and an AUC of 0.72.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352639,1790470677,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},137451211410,"https://ap-avatar.wpscdn.com/avatar/2000bb0a9246f588df?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786362646172706240","Article  \nREST and RASSF1A Tumor Suppressor Genes in Peripheral Blood: Potential Molecular Markers in Breast Cancer  \nMaria Eduarda R. de Oliveira 1, Marina P. Silva 1, Estella F. Silvestri 1, Samia F. Sanches 1, Isabella D. R. Trufelli 1, Ludmila F. B. Fabbrini 1, Glaucia L. da Veiga 1, Fernando Luiz A. Fonseca 1,2 and Beatriz da C. A. Alves 1, *  \nAcademic Editor: Christos Papadimitriou  \nReceived: 27 February 2026  \nRevised: 12 March 2026  \nAccepted: 16 March 2026  \nPublished: 18 March 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Laboratório de Análises Clínicas, Centro Universitário FMABC, Av. Principe de Gales, 821, Santo André 09060-950, São Paulo, Brazil; [maria.roliveira@aluno.fmabc.net](maria.roliveira@aluno.fmabc.net) (M.E.R.d.O.);  \n[marina.paschoal@aluno.fmabc.net](marina.paschoal@aluno.fmabc.net) (M.P.S.); [estella.silvestri@aluno.fmabc.net](estella.silvestri@aluno.fmabc.net) (E.F.S.);  \n[samia.sanches@aluno.fmabc.net](samia.sanches@aluno.fmabc.net) (S.F.S.); [isabella.trufelli@fmabc.br](isabella.trufelli@fmabc.br) (I.D.R.T.);  \nludmilla.fabbrini@fmabc.br (L.F.B.F.); [grlveiga@gmail.com](grlveiga@gmail.com) (G.L.d.V.); [profferfonseca@gmail.com](profferfonseca@gmail.com) (F.L.A.F.)  \n2 Departamento de Ciências Farmacêuticas, Universidade Federal de São Paulo, R. Prof. Artur Riedel, 275, Diadema 09972-270, São Paulo, Brazil  \n* [Correspondence: bcaalves@uol.com.br](Correspondence: bcaalves@uol.com.br); Tel.: +55-11-49935488  \nAbstract  \nTumor suppressor genes, such as RASSF1A and REST, play a central role in regulating cell proliferation. RASSF1A is frequently inactivated in various cancers, being associated with poor prognosis and metastasis. REST loss promotes the activation of genes related to invasion and estrogen sensitivity. We aimed to evaluate the expression of REST and RASSF1A in peripheral blood of breast cancer patients at different treatment stages and to associate the results with clinical and laboratory variables. Peripheral blood samples from breast cancer patients were collected at diagnosis and at 3 and 6 months after the start of chemotherapy; blood samples from healthy women were also collected. Gene expression was quantified by qPCR and associated with clinical variables. REST expression was significantly lower in patients (p \u003C 0.0001), showing a negative correlation with the BIRADS classification and an AUC of 0.72 . RASSF1A showed no significant difference between groups but was negatively correlated with heparanase (r = −0.4213; p \u003C 0.0001) . No relevant variations in gene expression were observed among the serial collections, nor associations with histological type. Downregulation of REST expression in the peripheral blood of breast cancer patients suggests its potential as an auxiliary biomarker for diagnosis and risk stratification. RASSF1A was correlated with mechanisms associated with tumor progression but did not differentiate patients from controls.  \nKeywords: neoplasm; tumor suppressor gene; biomarker; gene expression; peripheral blood  \n1. Introduction  \nBreast cancer is the most frequently diagnosed neoplasm among women worldwide, accounting for approximately 10% of all cancer diagnoses [1] . Malignant neoplasms are essentially understood as disorders of cell growth, since cancer development is amultistep process characterized by uncontrolled cell proliferation, invasion, and metastasis resulting from the accumulation of genetic and epigenetic alterations [2] . In this context, tumor suppressor genes (TSGs) play a crucial role in regulating and suppressing cell proliferation [3] .  \nTSGs are involved in DNA repair, cell division control, apoptosis induction, and metastasis suppression [4], and their loss of function can initiate and accelerate cancer  \nprogression [5] . p53 is the most extensively studied TSG, freq","cbCaijT1MhsNNRSH","https://ap.wps.com/l/cbCaijT1MhsNNRSH","pdf",932755,12,"English","# Abstract\n## Introduction","[{\"question\":\"What is the main aim of measuring REST and RASSF1A in this study?\",\"answer\":\"The study aims to evaluate REST and RASSF1A expression in the peripheral blood of breast cancer patients at different treatment stages and relate the findings to clinical and laboratory variables.\"},{\"question\":\"How were patient and control samples collected and analyzed?\",\"answer\":\"Peripheral blood samples were collected from breast cancer patients at diagnosis and at 3 and 6 months after starting chemotherapy, and from healthy women. Gene expression was quantified using qPCR and analyzed against clinical variables.\"},{\"question\":\"What did the study find regarding REST and clinical variables?\",\"answer\":\"REST expression was significantly lower in patients, with a negative correlation with BIRADS classification and an AUC of 0.72.\"}]","REST and RASSF1A Tumor Suppressor Genes in Peripheral Blood: Potential Molecular Markers in Breast Cancer | PDF",1790100591,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a0c6fee30499bb4d173216d7ae40ebf1.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5e22b7cd456eeb61aa78ef4ad5275e45.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a9cece0c71e8ceccc8dc3f2ff483ebb2.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3757feff855dfcef7bb8905d8f590698.webp",980,1385]